On your home page you explain:
We have developed an industry leading product line of hard pill formulations for a variety of cannabinoid (THC & CBD) blends in exacting dosages. Our proprietary cannabinoid formulations provide doctors, patients and the general consumer with a medical grade solution with all the features you would expect from any prescription or over the counter medication.
Recent market research suggests that two thirds of Canadians would opt to at least try a cannabis based drug if benefits covered the cost. How much of a roadblock is that and we are seeing some progress (Sunlife and Great West Life for example but only for a handful of medical conditions)?
Whether Sunlife or other insurance companies decide to cover cannabis is their purview. Ultimately, we’d like to have a DIN number and we’d like to be added to the Formulary for Health Canada, that will allow our medication to be covered by OHIP. The key to achieving this lies in our ability to complete clinical trials showing the efficacy of our formulations. Our study with Dr. Garbuz at UBC helps us move in this direction and we see it as being an integral part in our overall strategy to dominate the medical cannabis market with a next generation hard pill solution.
Consider this, as the evidence for the efficacy of cannabinoids piles up, doctors, who are primarily concerned with the well being of their patients and who are required to give the best treatment available, will begin prescribing cannabinoids. If the science is there, old stigmas and perceptions from a bygone era won’t stop the adoption of a drug that works, period. Insurance providers will likely follow close behind.
160